Michael A. Metzger, Chief Executive Officer of Syndax Pharmaceuticals Inc. (NASDAQ:SNDX), recently sold 13,288 shares of the company's common stock. The clinical-stage biopharmaceutical company, ...
The US-based fashion and accessories retailer speaks to Sky News about an element of its past that is haunting its present, ...
KSNW Wichita on MSN20h
Democrats vow hardball in shutdown fight: ‘I’m not a cheap date’House Democrats are vowing to play hardball in the partisan battle over government spending, driving to extract steep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback